|
1
|
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
|
Am J Psychiatry
|
2006
|
12.41
|
|
2
|
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
|
Control Clin Trials
|
2004
|
6.64
|
|
3
|
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
|
Biol Psychiatry
|
2007
|
5.59
|
|
4
|
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.
|
Psychiatr Clin North Am
|
2003
|
5.05
|
|
5
|
Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial.
|
Am J Psychiatry
|
2004
|
3.84
|
|
6
|
Report by the ACNP Task Force on response and remission in major depressive disorder.
|
Neuropsychopharmacology
|
2006
|
3.80
|
|
7
|
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
|
Arch Gen Psychiatry
|
2010
|
3.14
|
|
8
|
Parietal cortex and representation of the mental Self.
|
Proc Natl Acad Sci U S A
|
2004
|
2.73
|
|
9
|
Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial.
|
Neuropsychopharmacology
|
2008
|
2.31
|
|
10
|
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
|
Biol Psychiatry
|
2005
|
2.24
|
|
11
|
Effectiveness of electroconvulsive therapy in community settings.
|
Biol Psychiatry
|
2004
|
2.24
|
|
12
|
Response inhibition predicts poor antidepressant treatment response in very old depressed patients.
|
Am J Geriatr Psychiatry
|
2007
|
2.18
|
|
13
|
Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates.
|
J Neurosci
|
2007
|
2.12
|
|
14
|
Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis.
|
Arch Neurol
|
2003
|
2.08
|
|
15
|
Adequacy of antidepressant treatment after discharge and the occurrence of suicidal acts in major depression: a prospective study.
|
Am J Psychiatry
|
2002
|
1.95
|
|
16
|
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.
|
Biol Psychiatry
|
2005
|
1.90
|
|
17
|
Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report.
|
J Clin Psychiatry
|
2006
|
1.90
|
|
18
|
A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis.
|
Neural Comput
|
2005
|
1.78
|
|
19
|
Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression.
|
Am J Geriatr Psychiatry
|
2007
|
1.76
|
|
20
|
Vascular depression: A distinct diagnostic subtype?
|
Biol Psychiatry
|
2006
|
1.66
|
|
21
|
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
|
J ECT
|
2013
|
1.62
|
|
22
|
Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects.
|
Neuroimage
|
2003
|
1.62
|
|
23
|
Absence of histological lesions in primate models of ECT and magnetic seizure therapy.
|
Am J Psychiatry
|
2004
|
1.60
|
|
24
|
Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder.
|
Am J Psychiatry
|
2004
|
1.59
|
|
25
|
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes.
|
J Clin Psychiatry
|
2005
|
1.57
|
|
26
|
Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis.
|
Int J Neuropsychopharmacol
|
2002
|
1.51
|
|
27
|
A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
|
Biol Psychiatry
|
2005
|
1.48
|
|
28
|
Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates.
|
PLoS One
|
2011
|
1.45
|
|
29
|
Correlates of trait impulsiveness in performance measures and neuropsychological tests.
|
Psychiatry Res
|
2005
|
1.36
|
|
30
|
Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy.
|
Neuropsychopharmacology
|
2003
|
1.30
|
|
31
|
A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression.
|
J Clin Psychiatry
|
2003
|
1.21
|
|
32
|
Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes.
|
Biol Psychiatry
|
2002
|
1.17
|
|
33
|
Focal electrical stimulation as a sham control for repetitive transcranial magnetic stimulation: Does it truly mimic the cutaneous sensation and pain of active prefrontal repetitive transcranial magnetic stimulation?
|
Brain Stimul
|
2008
|
1.13
|
|
34
|
Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS).
|
Int J Neuropsychopharmacol
|
2005
|
1.08
|
|
35
|
Open-label trial of riluzole in generalized anxiety disorder.
|
Am J Psychiatry
|
2005
|
1.07
|
|
36
|
Neurophysiological characterization of magnetic seizure therapy (MST) in non-human primates.
|
Suppl Clin Neurophysiol
|
2003
|
1.05
|
|
37
|
Cognitive reserve-mediated modulation of positron emission tomographic activations during memory tasks in Alzheimer disease.
|
Arch Neurol
|
2004
|
1.05
|
|
38
|
Deep brain stimulation in movement and psychiatric disorders.
|
Biol Psychiatry
|
2006
|
1.05
|
|
39
|
Sertraline treatment of elderly patients with depression and cognitive impairment.
|
Int J Geriatr Psychiatry
|
2003
|
1.01
|
|
40
|
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.
|
Int J Geriatr Psychiatry
|
2008
|
1.01
|
|
41
|
Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
|
J ECT
|
2011
|
0.99
|
|
42
|
Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study.
|
Am J Psychiatry
|
2004
|
0.98
|
|
43
|
Predictors of remission after electroconvulsive therapy in unipolar major depression.
|
J Clin Psychiatry
|
2005
|
0.98
|
|
44
|
Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
|
Arch Gen Psychiatry
|
2007
|
0.96
|
|
45
|
Age-related characteristics of depression: a preliminary STAR*D report.
|
Am J Geriatr Psychiatry
|
2005
|
0.96
|
|
46
|
A primate model of anterograde and retrograde amnesia produced by convulsive treatment.
|
J ECT
|
2004
|
0.94
|
|
47
|
Acceptability of second-step treatments to depressed outpatients: a STAR*D report.
|
Am J Psychiatry
|
2007
|
0.93
|
|
48
|
Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.
|
Ann Clin Psychiatry
|
2007
|
0.93
|
|
49
|
Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS).
|
Brain Stimul
|
2009
|
0.92
|
|
50
|
A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.
|
Int J Geriatr Psychiatry
|
2010
|
0.91
|
|
51
|
Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT.
|
J Affect Disord
|
2012
|
0.91
|
|
52
|
Electroconvulsive therapy in treatment-resistant schizophrenia: prediction of response and the nature of symptomatic improvement.
|
J ECT
|
2010
|
0.90
|
|
53
|
Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression.
|
Depress Anxiety
|
2011
|
0.90
|
|
54
|
A feasibility study of a new method for electrically producing seizures in man: focal electrically administered seizure therapy [FEAST].
|
Brain Stimul
|
2013
|
0.89
|
|
55
|
Focal electrically administered therapy: device parameter effects on stimulus perception in humans.
|
J ECT
|
2009
|
0.89
|
|
56
|
Adverse life events in elderly patients with major depression or dysthymic disorder and in healthy-control subjects.
|
Am J Geriatr Psychiatry
|
2002
|
0.88
|
|
57
|
Response to Drs Abrams and Kellner: the cognitive effects of ECT in community settings.
|
J ECT
|
2007
|
0.88
|
|
58
|
Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial.
|
Brain Stimul
|
2012
|
0.88
|
|
59
|
A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.
|
J Clin Psychiatry
|
2014
|
0.86
|
|
60
|
Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.
|
Depress Anxiety
|
2012
|
0.86
|
|
61
|
Are cognitive symptoms of schizophrenia mediated by abnormalities in emotional arousal?
|
CNS Spectr
|
2002
|
0.85
|
|
62
|
Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects.
|
Neuropsychopharmacology
|
2004
|
0.84
|
|
63
|
Self-evaluation of the cognitive effects of electroconvulsive therapy.
|
J ECT
|
2011
|
0.84
|
|
64
|
The WAIS-III and major depression: absence of VIQ/PIQ differences.
|
J Clin Exp Neuropsychol
|
2006
|
0.84
|
|
65
|
Subjective evaluation of the therapeutic and cognitive effects of electroconvulsive therapy.
|
Brain Stimul
|
2007
|
0.83
|
|
66
|
New developments in electroconvulsive therapy and magnetic seizure therapy.
|
CNS Spectr
|
2003
|
0.83
|
|
67
|
Neurobiological correlates of the cognitive side effects of electroconvulsive therapy.
|
J ECT
|
2008
|
0.83
|
|
68
|
Effects of medications on cerebral blood flow in late-life depression.
|
Curr Psychiatry Rep
|
2002
|
0.82
|
|
69
|
Brain stimulation-basic, translational, and clinical research in neuromodulation: Why a new journal?
|
Brain Stimul
|
2007
|
0.82
|
|
70
|
Clinical trials in late-life depression: revisited.
|
Am J Geriatr Psychiatry
|
2002
|
0.79
|
|
71
|
Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder.
|
Am J Geriatr Psychiatry
|
2005
|
0.79
|
|
72
|
Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy.
|
Arch Gen Psychiatry
|
2009
|
0.79
|
|
73
|
The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial.
|
Brain Stimul
|
2013
|
0.78
|
|
74
|
Length of the ECT course in bipolar and unipolar depression.
|
J ECT
|
2005
|
0.78
|
|
75
|
Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders.
|
Int J Neuropsychopharmacol
|
2003
|
0.78
|
|
76
|
Reply regarding "efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial".
|
Biol Psychiatry
|
2010
|
0.78
|
|
77
|
An open treatment trial of venlafaxine for elderly patients with dysthymic disorder.
|
J Geriatr Psychiatry Neurol
|
2004
|
0.77
|
|
78
|
Brain stimulation, revolutions, and the shifting time domain of depression.
|
Biol Psychiatry
|
2008
|
0.77
|
|
79
|
Role of hippocampal neurogenesis in mnemonic segregation: implications for human mood disorders.
|
World J Biol Psychiatry
|
2013
|
0.77
|
|
80
|
WAIS-III and WMS-III performance in chronic Lyme disease.
|
J Int Neuropsychol Soc
|
2006
|
0.76
|
|
81
|
Expanded Safety and Efficacy Data for a New Method of Performing Electroconvulsive Therapy: Focal Electrically Administered Seizure Therapy.
|
J ECT
|
2016
|
0.75
|
|
82
|
It is time to take a stand for medical research and against terrorism targeting medical scientists.
|
Biol Psychiatry
|
2008
|
0.75
|
|
83
|
In memoriam--Vahe E. Amassian.
|
Brain Stimul
|
2013
|
0.75
|
|
84
|
Antidepressant treatment of melancholia in older adults.
|
Am J Geriatr Psychiatry
|
2013
|
0.75
|